NME Submissions See “Modest” Rise In 2005 – Parexel’s Bio/Pharma Report
Executive Summary
New molecular entity submissions reached a six-year high in 2005, a slight increase from the previous year, according to Parexel's Bio/Pharmaceutical R&D Statistical Sourcebook 2006/2007